Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone Gel + MODD vs Ketanserin in Diabetic Foot Ulcers
NCT02632877Phase 2Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Jan 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in diabetic foot ulcer (DFU), sponsored by Universidad de Guadalajara. Started Jan 2014; status: completed.
02
Drugs
pirfenidone
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02632877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02632877.